PR Newswire Clinical TrialsOriginal article
Rhythm AI's STAR Apollo Mapping Technology Demonstrates 90% of Patients Experienced Freedom from Atrial Fibrillation (AF) at One-Year Following Redo Ablations for Persistent AF
ConferencepositiveSTAR Apollo Mapping SystemPositive
AI Analysis
Summary
Rhythm AI's STAR Apollo Mapping System demonstrated positive results in a late-breaking study presented at HRX 2026, with 90% of persistent AF patients achieving freedom from atrial fibrillation at one-year post-redo ablation and 100% of patients meeting the primary feasibility endpoint.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
90% of patients experienced freedom from atrial fibrillation at one-year following redo ablations; primary feasibility endpoint met in 100% of patients
Importance:6/10
Sentiment:
0.80
atrial fibrillationablationcardiac arrhythmiamapping technologyHRX 2026clinical data
Read the original article
Published by PR Newswire Clinical Trials on September 22, 2026 1:04 PM